Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FSME-Immun Rapid Immunisation Schedules for TBE
NCT00890422Phase 2Unknown
- Sponsor
- Elisabethinen Hospital
- Start
- Mar 2007
- Primary completion
- Nov 2009
- Modality
- Whole Inactivated Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of FSME-IMMUN in tick-borne encephalitis (TBE), sponsored by Elisabethinen Hospital. Status: unknown.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on NCT00890422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00890422.